Pharma Distribution as Strategy: Access, Scale, and Value
28 January 2026.
Pharma distribution is becoming a strategic lever shaping access, affordability, scale.
Article
Clinical Trial Supply & Logistics: When Execution Risks Delivery
21 January 2026.
Clinical trial supply chains have become strategic engines of feasibility, resilience, and value.
Precision at Scale: The Business of Genome Editing
14 January 2026.
Genome editing shifts toward execution as CRISPR matures, partnerships scale delivery, manufacturing, regulatory readiness.
Cold Chain Logistics: Building Resilient Healthcare Systems
7 January 2026.
Cold chain logistics becomes strategic infrastructure, enabling biologics, vaccines, advanced therapies at global scale.
Liver Fibrosis and NASH: Entering a Critical Execution Phase
31 December 2025.
Liver fibrosis and NASH enter execution phase as late-stage pipelines, regulation, partnerships align globally
mRNA Revolution: Redefining the Future of Cancer Care and Beyond
24 December 2025.
mRNA cancer vaccines advance toward oncology reality, driven by personalisation, combination therapies, scalable manufacturing.
Scale vs Specialisation: Defining the Competitive Edge for CDMOs
26 November 2025.
Hybrid CDMOs achieve stronger retention and resilience as demand grows for multimodality, globally scalable manufacturing.
Hybrid Generics & VAMs Accelerate the Innovation Curve
19 November 2025.
Differentiated hybrids and VAMs strengthen competitiveness, extend lifecycles and unlock sustainable growth beyond price competition.
Modality-Driven Innovation in the Biologics Landscape
5 November 2025.
Modality convergence, platform innovation and CDMO investment are accelerating biologics growth across global markets.
Digital Minds: The Fusion of Psychology and Neurotechnology
22 October 2025.
Digital therapeutics and neurotech ecosystems are evolving into regulated, scalable infrastructure for mental health.
Precision at the Periphery: Last-Mile Diagnostics and the Future of Healthcare Logistics
15 October 2025.
From lab to doorstep, digital logistics are becoming the backbone of decentralised global healthcare delivery.
Beyond Monotherapy: Unlocking the Promise of Combination Therapies
8 October 2025.
The move from monotherapy to combination therapy marks a pivotal change in how medicine addresses complex diseases.
Digital Diagnostics: Redefining the Value Chain of Modern Healthcare
1 October 2025.
From lab to cloud, digital diagnostics are becoming infrastructure-grade, interoperable pillars of modern healthcare.
Immunochemistry: Empowering Precision Medicine
24 September 2025.
Immunohistochemistry links molecular biomarkers with digital pathology, driving precision oncology and personalised treatment decisions.
Precision Oncology: From Biomarkers to Market Impact
17 September 2025.
Rising biomarker trials, FDA approvals, and AI integration define the next growth phase in oncology.
mRNA Contract Manufacturing: The Emergent White Space for CDMOs
10 September 2025.
Scaling fragile mRNA demands advanced CDMO integration, automated quality control, and −80°C infrastructure maturity.
Cell & Gene Therapy Manufacturing: The Next Frontiers of Scalability and Strategy
3 September 2025.
AI, robotics, and digital twins are transforming CGT manufacturing into intelligent, automated production ecosystems.
AI at the Helm: How Generative & Agentic AI Are Reshaping Drug Discovery
27 August 2025.
Pharma leaders integrating AI, data, and regulatory strategy are redefining speed, scalability, and R&D success.
Cloud Security Market
24 May 2024.
The global Cloud Security market was valued at US$41.15 billion in 2023 and is projected to grow at a CAGR of 12.7% during the forecast period 2024-2034.
